Teva Pharmaceutical Industries Limited (TEVA) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Teva Pharmaceutical Industries Limited  (NYSE: TEVA)
 

Teva Pharmaceutical Industries Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Teva Pharmaceutical Industries Limited's inventory turnover ratio sequentially decreased to 3.66 in the second quarter 2026, unsurprisingly, as the Teva Pharmaceutical Industries Limited markets continue to deteriorate, and TEVA's faces growing challenges to bring down its inventories. Teva Pharmaceutical Industries Limited's average inventory processing period in the Jun 30 2026 quarter, has increased to 100 days, from 86 days, in the Mar 31 2026 quarter.

Within Healthcare sector 106 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 521 in the first quarter 2026, to 921.

TEVA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Teva Pharmaceutical Industries Limited Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TEVA Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 52.94 % -2.48 % 6.79 % -12.4 % -7.18 %
Y / Y Cost of Sales Growth -4.1 % -0.15 % -2.56 % -0.32 % -3.08 %
Inventory Turnover Ratio (TTM) 3.66 4.22 4.2 4.29 4.14
TEVA's Total Ranking # 921 # 521 # 361 # 840 # 398
Average inventory processing period 100 87 87 85 88
Seq. Inventory Growth 74.3 % -2.94 % -6.07 % -3.75 % 11.13 %
Seq. Cost of Sales Growth -1.09 % -2.19 % -5.51 % 4.92 % 2.98 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 23
Healthcare Sector # 107
Overall Market # 921

Inventory Turnover Ratio Statistics
High Average Low
4.64 3.83 2.21
(Sep 30 2014)   (Dec 31 2009)



TEVA Company Profile >> Back to TEVA Efficiency Comparisons >> Compare TEVA Inventory Turnover Ratio to its Competitors

Financial Statements
Teva Pharmaceutical Industries Limited's Inventories $ 3,221 Millions Visit TEVA's Balance sheet
Teva Pharmaceutical Industries Limited's Cost of Revenues TTM $ 8,232 Millions Visit TEVA's Income Statement
What are TEVA's Sales? Visit TEVA's Sales by Segment

Other Inventory Turnover Ratios
Teva Pharmaceutical Industries Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TEVA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TEVA's Competitors
Inventory Turnover Ratio for TEVA's Suppliers
Inventory Turnover Ratio for TEVA's Customers

You may also want to know
TEVA's Sales Growth Rates TEVA's Pe Price to earnings ratio TEVA's Receivables Turnover Ratio TEVA's Stock Quote
TEVA's Net Income Growth Rates TEVA's Ps Price to Sales ratio TEVA's Sales per Employee TEVA's Asset Turnover Ratio
TEVA's Net Margin TEVA's Pb Price to Book ratio TEVA's Financial Strength Ratios TEVA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions

Date modified: 2026-08-12T20:54:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.